Women’s Health: Contemporary Management of MS in Pregnancy and Post-Partum
AbstractMultiple sclerosis (MS) primarily affects women in childbearing age and is associated with an increased risk of adverse post-partum outcomes. Relapses and now fetal exposure to disease modifying treatments in the early phase of pregnancy and thereafter are of concern. Safe and effective contraception is required for women who wish to delay or avoid pregnancy while on disease-modifying treatments. Counseling and planning is essential to assess the risk of both fetal and maternal complications, particularly now in the era of highly efficient and riskier therapies. The purpose of this review is to provide a practical framework using the available data surrounding pregnancy in MS with the goal of optimizing outcomes during this phase in MS. View Full-Text
- Supplementary File 1:
DOCX-Document (DOCX, 63 KB)
Share & Cite This Article
Tisovic, K.; Amezcua, L. Women’s Health: Contemporary Management of MS in Pregnancy and Post-Partum. Biomedicines 2019, 7, 32.
Tisovic K, Amezcua L. Women’s Health: Contemporary Management of MS in Pregnancy and Post-Partum. Biomedicines. 2019; 7(2):32.Chicago/Turabian Style
Tisovic, Kelly; Amezcua, Lilyana. 2019. "Women’s Health: Contemporary Management of MS in Pregnancy and Post-Partum." Biomedicines 7, no. 2: 32.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.